A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/19 (2006.01)
Patent
CA 2675623
An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF against may be a VEGF peptide or a gene construct encoding or expressing such a peptide.
L'invention concerne un agoniste du récepteur de VEGF servant à traiter une maladie associée à un retard de croissance foetale, notamment un retard de croissance intra-utérine. L'agoniste de VEGF peut-être un peptide de VEGF ou une construction génique codant ou exprimant un tel peptide.
Martin John Francis
Rodeck Charles Henry
Ark Therapeutics Ltd.
Torys Llp
LandOfFree
Use of vegf in the treatment of retarded fetal growth in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of vegf in the treatment of retarded fetal growth in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of vegf in the treatment of retarded fetal growth in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1375094